Peptide Briefing

GLP-1 Therapies Market Set for Rapid Growth Through 2034 as Obesity and Diabetes Demand, Drug Innovation, and Expanding Indications Fuel New Business Opportunities

GLP-1 demand is expanding beyond diabetes into obesity and cardiometabolic care, creating opportunities in oral drugs, next-gen agonists, biosimilars, manufacturing and Asia-Pacific. GLP-1 demand is expanding beyond diabetes into obesity and cardiometabolic care, creating opportunities in oral drugs, next-gen agonists, biosimilars, manufacturing and Asia-Pacific.

By Peptide Briefing · September 16, 2026 · 1 min read

GLP-1 demand is expanding beyond diabetes into obesity and cardiometabolic care, creating opportunities in oral drugs, next-gen agonists, biosimilars, manufacturing and Asia-Pacific. GLP-1 demand is expanding beyond diabetes into obesity and cardiometabolic care, creating opportunities in oral drugs, next-gen agonists, biosimilars, manufacturing and Asia-Pacific.

Source: Globenewswire_fr

This item was collected automatically from an official industry feed. Follow the source link for the complete announcement and primary documentation.